24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
@Finance
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Uveitis
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
15:27
Why the world still isn't visiting Israel
15:12
CTech’s Book Review: Meaningful networking starts long before you need anything
14:14
KPMG: “Addressing burnout is not necessarily about a specific benefit or perk”
13:57
Israel’s teenage G.I. Janes are preparing for the battlefield
More stories
Buzz
Most popular
Daily
Weekly
1
Cyberbit shuts down Israeli operations, lays off local workforce
2
AI startup Engram raises $98 million at $600 million valuation with just 13 employees
3
Assaf Rappaport’s 2026 deal spree: Inside the Wiz founder’s expanding AI investment map
4
“I will have nothing when I leave this world” — Daniel Jusidman on philanthropy and giving away his fortune at 91
5
The 50 most promising Israeli startups - 2026
More news
Uveitis
1 stories about Uveitis
How one female CEO overcame adversity to find a cure for Uveitis
04.02.22
|
Roni Dori
"I see us building a large company that will focus on the eye, beyond Uveitis. Our technology has tremendous potential to treat other diseases that cause blindness, and treat millions of patients," says Dr. Daphne Haim-Langford, who suffers from Uveitis and founded Tarsier Pharma
